Cash reward system will hurt pharmaceutical sector

Korea’s pharmaceutical sector could lose up to 1.4 trillion won due to the current drug pricing reform, which has provided cash rewards to doctors and pharmacists who refuse to take rebates and instead purchase medicines at lower prices, according a report released by the Korea Pharmaceutical Manufacturers Association.

The estimated losses are based on the assumption of unreasonable discount...